1. Home
  2. NPKI vs EYPT Comparison

NPKI vs EYPT Comparison

Compare NPKI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

HOLD

Current Price

$14.27

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$13.97

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
EYPT
Founded
1932
1987
Country
United States
United States
Employees
510
N/A
Industry
Metal Fabrications
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
NPKI
EYPT
Price
$14.27
$13.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$14.17
$31.80
AVG Volume (30 Days)
1.2M
1.4M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,539,000.00
Revenue This Year
$16.39
N/A
Revenue Next Year
$11.70
$3,115.57
P/E Ratio
$38.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.17
$9.41
52 Week High
$16.50
$19.11

Technical Indicators

Market Signals
Indicator
NPKI
EYPT
Relative Strength Index (RSI) 42.67 55.34
Support Level $13.70 $12.01
Resistance Level $15.28 $14.52
Average True Range (ATR) 0.77 1.05
MACD -0.06 0.08
Stochastic Oscillator 13.16 51.38

Price Performance

Historical Comparison
NPKI
EYPT

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. It generates maximum revenue from United States.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: